Bioprocess Digital Twin Market Report 2026

Bioprocess Digital Twin Market Overview

• Bioprocess Digital Twin market size has reached to $1.63 billion in 2025 • Expected to grow to $4.88 billion in 2030 at a compound annual growth rate (CAGR) of 24.6% • Growth Driver: Rise In Biopharmaceutical Production Driving The Market Growth Due To Increasing R&D Investment • Market Trend: Advancements In Bioprocess Digital Twin Technology Enhance Process Control And Manufacturing Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioprocess Digital Twin Market?

A bioprocess digital twin is a virtual representation of a biological manufacturing process that simulates its behavior in real time. It integrates data from sensors, laboratory results, and historical process information to predict outcomes and optimize performance. This technology helps improve efficiency, reduce costs, and enhance product quality by allowing operators to test and refine processes virtually before applying changes in the real system. The main components of bioprocess digital twin include software, hardware, and services. Software refers to platforms that simulate, monitor, and optimize bioprocess operations in real time to improve efficiency, quality, and predictive insights. These solutions are deployed in modes such as on-premises and cloud. They are applied across areas including process optimization, predictive maintenance, quality management, performance monitoring, and other applications, and are used by end users including pharmaceutical and biotechnology companies, contract manufacturing organizations, academic and research institutes, and other end users.

What Is The Bioprocess Digital Twin Market Growth Forecast?

The bioprocess digital twin market size is expected to see exponential growth in the next few years. It will grow to $4.88 billion in 2030 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to increasing investments in smart biomanufacturing platforms, rising demand for real-time decision support tools, expansion of digital quality management systems, growing regulatory acceptance of digital twins, increasing focus on cost and risk reduction. Major trends in the forecast period include increasing adoption of real-time bioprocess simulation, rising integration of predictive analytics in manufacturing, expansion of closed-loop process optimization, growing use of virtual commissioning tools, enhanced focus on regulatory-compliant digital validation.

Global Bioprocess Digital Twin Market Segmentation

1) By Component: Software; Hardware; Services 2) By Deployment Mode: On-Premises; Cloud 3) By Application: Process Optimization; Predictive Maintenance; Quality Management; Performance Monitoring; Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies; Contract Manufacturing Organizations; Academic And Research Institutes; Other End-Users Subsegments: 1) By Software: Modeling Platforms; Simulation Engines; Analytics Software 2) By Hardware: Sensors; Internet Of Things Devices; Computing Infrastructure 3) By Services: Consulting Services; System Integration Services; Maintenance Services; Training Services

What Is The Driver Of The Bioprocess Digital Twin Market?

The rise in biopharmaceutical production is expected to propel the growth of the bioprocess digital twin market going forward. Biopharmaceutical production refers to the manufacturing and development of therapeutic products derived from biological sources such as living cells, proteins, and nucleic acids. The growth in biopharmaceutical production is driven by increasing investment in research and development, as pharmaceutical companies allocate substantial resources to discover and manufacture innovative biological therapies for chronic and rare diseases. Higher biopharmaceutical production volumes create greater demand for digital twin technologies that enable real-time monitoring, optimization, and predictive modeling of complex bioprocessing systems. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the rise in biopharmaceutical production is driving the growth of the bioprocess digital twin industry.

Key Players In The Global Bioprocess Digital Twin Market

Major companies operating in the bioprocess digital twin market are Siemens Aktiengesellschaft, General Electric Company, Schneider Electric SE, Honeywell International Inc., ABB Ltd, Emerson Electric Co., Rockwell Automation Inc., Dassault Systèmes SE, Cytiva Sweden AB, Mettler Toledo International Inc., Sartorius Aktiengesellschaft, WuXi Biologics Cayman Inc., ANSYS Inc., PTC Inc., AVEVA Group plc, Aspen Technology Inc., Aizon Ltd, TwinThread Inc., Intelligen Inc., and Novasign GmbH.

Global Bioprocess Digital Twin Market Trends and Insights

Major companies operating in the bioprocess digital twin market are focusing on technological advancement in process simulation, such as digital twin-based bioprocess development platforms, to enhance process predictability, improve product quality, and reduce development timelines. A digital twin–based bioprocess development platform creates a virtual model of an actual bioprocess using real-time data, advanced modeling, and simulation to accurately predict process performance and enhance product quality by allowing process scenarios to be evaluated digitally before physical execution. For instance, in January 2026, WuXi Biologics, a China-based contract research, development, and manufacturing organization, launched PatroLabTM, a state-of-the-art bioprocess digital twin platform to support advanced bioprocess development and manufacturing. It integrates real-time process monitoring with Raman-based Process Analytical Technology (PAT) and predictive in-silico modeling. The platform continuously incorporates live process data into virtual models, enabling real-time analytics and proactive process control. PatroLab helps detect process deviations early, reduce operational risks, and improve process consistency.

What Are Latest Mergers And Acquisitions In The Bioprocess Digital Twin Market?

In July 2025, Repligen Corporation, a US-based provider of bioprocessing technologies and solutions, entered into a strategic partnership with Novasign to advance bioprocess digitalization by leveraging digital twin and predictive modeling technologies for smarter biomanufacturing. The partnership aims to integrate Novasign’s bioprocess digital twin platform into Repligen’s bioprocessing portfolio, enabling enhanced process understanding, virtual simulation, and optimization across biologics development and manufacturing. Novasign is an Austria-based developer of bioprocess digital twins for biologics development and manufacturing.

Regional Insights

North America was the largest region in the bioprocess digital twin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bioprocess Digital Twin Market?

The bioprocess digital twin market consists of revenues earned by entities by providing services such as process modeling and simulation services, bioprocess optimization services, predictive analytics and forecasting services, real-time monitoring and visualization services, system integration and deployment services, validation and regulatory support services, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess digital twin market also includes sales of digital twin software platforms, bioprocess simulation tools, data analytics and visualization tools, process control and optimization software, virtual commissioning tools, and lifecycle management software. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioprocess Digital Twin Market Report 2026?

The bioprocess digital twin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess digital twin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.